 | • レポートコード：MRC2-11QY11174 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はボツリヌス中毒治療のグローバル市場について調査・分析したレポートです。種類別（抗毒素、抗生物質、その他）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ボツリヌス中毒治療の競争状況、市場シェア ・世界のボツリヌス中毒治療市場：種類別市場規模 2015年-2020年（抗毒素、抗生物質、その他） ・世界のボツリヌス中毒治療市場：種類別市場規模予測 2021年-2026年（抗毒素、抗生物質、その他） ・世界のボツリヌス中毒治療市場：用途別市場規模 2015年-2020年（病院・クリニック、その他） ・世界のボツリヌス中毒治療市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他） ・北米のボツリヌス中毒治療市場分析：米国、カナダ ・ヨーロッパのボツリヌス中毒治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのボツリヌス中毒治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のボツリヌス中毒治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのボツリヌス中毒治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：XOMA (U.S.)、Microbiotix (U.S.)、Valeant Pharmaceuticals (Canada)、Morphotek (U.S.)、Medytox Solutions (U.S.)、Lanzhou Institute of Biological Products (China)、Mentor Corporation and Metabiologics (U.S.)、Merz Pharma (Germany)、Allergan (Irish)、Galderma (Switzerland) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Botulism is a type of poisoning or infection caused by certain bacteria on the preserved food material.
The overall botulism market also provides a detailed analysis of the type and treatment in various regions which includes Americas, Europe, Asia Pacific and Rest of the World. Americas lead the botulism market owing to the largest number of botulism cases every year.
Market Analysis and Insights: Global Botulism Treatment Market
The global Botulism Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Botulism Treatment Scope and Market Size
Botulism Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Botulism Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
XOMA (U.S.)
Microbiotix (U.S.)
Valeant Pharmaceuticals (Canada)
Morphotek (U.S.)
Medytox Solutions (U.S.)
Lanzhou Institute of Biological Products (China)
Mentor Corporation and Metabiologics (U.S.)
Merz Pharma (Germany)
Allergan (Irish)
Galderma (Switzerland)
Market segment by Type, the product can be split into
Antitoxin
Antibiotics
Others
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Botulism Treatment Revenue
1.4 Market by Type
1.4.1 Global Botulism Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antitoxin
1.4.3 Antibiotics
1.4.4 Others
1.5 Market by Application
1.5.1 Global Botulism Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Botulism Treatment Market Perspective (2015-2026)
2.2 Global Botulism Treatment Growth Trends by Regions
2.2.1 Botulism Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Botulism Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Botulism Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Botulism Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Botulism Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Botulism Treatment Players by Market Size
3.1.1 Global Top Botulism Treatment Players by Revenue (2015-2020)
3.1.2 Global Botulism Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Botulism Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Botulism Treatment Market Concentration Ratio
3.2.1 Global Botulism Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Botulism Treatment Revenue in 2019
3.3 Botulism Treatment Key Players Head office and Area Served
3.4 Key Players Botulism Treatment Product Solution and Service
3.5 Date of Enter into Botulism Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Botulism Treatment Historic Market Size by Type (2015-2020)
4.2 Global Botulism Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Botulism Treatment Market Size by Application (2015-2020)
5.2 Global Botulism Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Botulism Treatment Market Size (2015-2020)
6.2 Botulism Treatment Key Players in North America (2019-2020)
6.3 North America Botulism Treatment Market Size by Type (2015-2020)
6.4 North America Botulism Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Botulism Treatment Market Size (2015-2020)
7.2 Botulism Treatment Key Players in Europe (2019-2020)
7.3 Europe Botulism Treatment Market Size by Type (2015-2020)
7.4 Europe Botulism Treatment Market Size by Application (2015-2020)
8 China
8.1 China Botulism Treatment Market Size (2015-2020)
8.2 Botulism Treatment Key Players in China (2019-2020)
8.3 China Botulism Treatment Market Size by Type (2015-2020)
8.4 China Botulism Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Botulism Treatment Market Size (2015-2020)
9.2 Botulism Treatment Key Players in Japan (2019-2020)
9.3 Japan Botulism Treatment Market Size by Type (2015-2020)
9.4 Japan Botulism Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Botulism Treatment Market Size (2015-2020)
10.2 Botulism Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Botulism Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Botulism Treatment Market Size by Application (2015-2020)
11 India
11.1 India Botulism Treatment Market Size (2015-2020)
11.2 Botulism Treatment Key Players in India (2019-2020)
11.3 India Botulism Treatment Market Size by Type (2015-2020)
11.4 India Botulism Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Botulism Treatment Market Size (2015-2020)
12.2 Botulism Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Botulism Treatment Market Size by Type (2015-2020)
12.4 Central & South America Botulism Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 XOMA (U.S.)
13.1.1 XOMA (U.S.) Company Details
13.1.2 XOMA (U.S.) Business Overview
13.1.3 XOMA (U.S.) Botulism Treatment Introduction
13.1.4 XOMA (U.S.) Revenue in Botulism Treatment Business (2015-2020))
13.1.5 XOMA (U.S.) Recent Development
13.2 Microbiotix (U.S.)
13.2.1 Microbiotix (U.S.) Company Details
13.2.2 Microbiotix (U.S.) Business Overview
13.2.3 Microbiotix (U.S.) Botulism Treatment Introduction
13.2.4 Microbiotix (U.S.) Revenue in Botulism Treatment Business (2015-2020)
13.2.5 Microbiotix (U.S.) Recent Development
13.3 Valeant Pharmaceuticals (Canada)
13.3.1 Valeant Pharmaceuticals (Canada) Company Details
13.3.2 Valeant Pharmaceuticals (Canada) Business Overview
13.3.3 Valeant Pharmaceuticals (Canada) Botulism Treatment Introduction
13.3.4 Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2015-2020)
13.3.5 Valeant Pharmaceuticals (Canada) Recent Development
13.4 Morphotek (U.S.)
13.4.1 Morphotek (U.S.) Company Details
13.4.2 Morphotek (U.S.) Business Overview
13.4.3 Morphotek (U.S.) Botulism Treatment Introduction
13.4.4 Morphotek (U.S.) Revenue in Botulism Treatment Business (2015-2020)
13.4.5 Morphotek (U.S.) Recent Development
13.5 Medytox Solutions (U.S.)
13.5.1 Medytox Solutions (U.S.) Company Details
13.5.2 Medytox Solutions (U.S.) Business Overview
13.5.3 Medytox Solutions (U.S.) Botulism Treatment Introduction
13.5.4 Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2015-2020)
13.5.5 Medytox Solutions (U.S.) Recent Development
13.6 Lanzhou Institute of Biological Products (China)
13.6.1 Lanzhou Institute of Biological Products (China) Company Details
13.6.2 Lanzhou Institute of Biological Products (China) Business Overview
13.6.3 Lanzhou Institute of Biological Products (China) Botulism Treatment Introduction
13.6.4 Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2015-2020)
13.6.5 Lanzhou Institute of Biological Products (China) Recent Development
13.7 Mentor Corporation and Metabiologics (U.S.)
13.7.1 Mentor Corporation and Metabiologics (U.S.) Company Details
13.7.2 Mentor Corporation and Metabiologics (U.S.) Business Overview
13.7.3 Mentor Corporation and Metabiologics (U.S.) Botulism Treatment Introduction
13.7.4 Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2015-2020)
13.7.5 Mentor Corporation and Metabiologics (U.S.) Recent Development
13.8 Merz Pharma (Germany)
13.8.1 Merz Pharma (Germany) Company Details
13.8.2 Merz Pharma (Germany) Business Overview
13.8.3 Merz Pharma (Germany) Botulism Treatment Introduction
13.8.4 Merz Pharma (Germany) Revenue in Botulism Treatment Business (2015-2020)
13.8.5 Merz Pharma (Germany) Recent Development
13.9 Allergan (Irish)
13.9.1 Allergan (Irish) Company Details
13.9.2 Allergan (Irish) Business Overview
13.9.3 Allergan (Irish) Botulism Treatment Introduction
13.9.4 Allergan (Irish) Revenue in Botulism Treatment Business (2015-2020)
13.9.5 Allergan (Irish) Recent Development
13.10 Galderma (Switzerland)
13.10.1 Galderma (Switzerland) Company Details
13.10.2 Galderma (Switzerland) Business Overview
13.10.3 Galderma (Switzerland) Botulism Treatment Introduction
13.10.4 Galderma (Switzerland) Revenue in Botulism Treatment Business (2015-2020)
13.10.5 Galderma (Switzerland) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Botulism Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Botulism Treatment Revenue
Table 3. Ranking of Global Top Botulism Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Botulism Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antitoxin
Table 6. Key Players of Antibiotics
Table 7. Key Players of Others
Table 8. Global Botulism Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Botulism Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Botulism Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Botulism Treatment Market Share by Regions (2015-2020)
Table 12. Global Botulism Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Botulism Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Botulism Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Botulism Treatment Players
Table 19. Global Botulism Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Botulism Treatment Market Share by Players (2015-2020)
Table 21. Global Top Botulism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Treatment as of 2019)
Table 22. Global Botulism Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Botulism Treatment Product Solution and Service
Table 25. Date of Enter into Botulism Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Botulism Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Botulism Treatment Market Size Share by Type (2015-2020)
Table 29. Global Botulism Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Botulism Treatment Market Size Share by Application (2015-2020)
Table 31. Global Botulism Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Botulism Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Botulism Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Botulism Treatment Market Share (2019-2020)
Table 35. North America Botulism Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Botulism Treatment Market Share by Type (2015-2020)
Table 37. North America Botulism Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Botulism Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Botulism Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Botulism Treatment Market Share (2019-2020)
Table 41. Europe Botulism Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Botulism Treatment Market Share by Type (2015-2020)
Table 43. Europe Botulism Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Botulism Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Botulism Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Botulism Treatment Market Share (2019-2020)
Table 47. China Botulism Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Botulism Treatment Market Share by Type (2015-2020)
Table 49. China Botulism Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Botulism Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Botulism Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Botulism Treatment Market Share (2019-2020)
Table 53. Japan Botulism Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Botulism Treatment Market Share by Type (2015-2020)
Table 55. Japan Botulism Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Botulism Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Botulism Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Botulism Treatment Market Share (2019-2020)
Table 59. Southeast Asia Botulism Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Botulism Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Botulism Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Botulism Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Botulism Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Botulism Treatment Market Share (2019-2020)
Table 65. India Botulism Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Botulism Treatment Market Share by Type (2015-2020)
Table 67. India Botulism Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Botulism Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Botulism Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Botulism Treatment Market Share (2019-2020)
Table 71. Central & South America Botulism Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Botulism Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Botulism Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Botulism Treatment Market Share by Application (2015-2020)
Table 75. XOMA (U.S.) Company Details
Table 76. XOMA (U.S.) Business Overview
Table 77. XOMA (U.S.) Product
Table 78. XOMA (U.S.) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 79. XOMA (U.S.) Recent Development
Table 80. Microbiotix (U.S.) Company Details
Table 81. Microbiotix (U.S.) Business Overview
Table 82. Microbiotix (U.S.) Product
Table 83. Microbiotix (U.S.) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 84. Microbiotix (U.S.) Recent Development
Table 85. Valeant Pharmaceuticals (Canada) Company Details
Table 86. Valeant Pharmaceuticals (Canada) Business Overview
Table 87. Valeant Pharmaceuticals (Canada) Product
Table 88. Valeant Pharmaceuticals (Canada) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 89. Valeant Pharmaceuticals (Canada) Recent Development
Table 90. Morphotek (U.S.) Company Details
Table 91. Morphotek (U.S.) Business Overview
Table 92. Morphotek (U.S.) Product
Table 93. Morphotek (U.S.) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 94. Morphotek (U.S.) Recent Development
Table 95. Medytox Solutions (U.S.) Company Details
Table 96. Medytox Solutions (U.S.) Business Overview
Table 97. Medytox Solutions (U.S.) Product
Table 98. Medytox Solutions (U.S.) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 99. Medytox Solutions (U.S.) Recent Development
Table 100. Lanzhou Institute of Biological Products (China) Company Details
Table 101. Lanzhou Institute of Biological Products (China) Business Overview
Table 102. Lanzhou Institute of Biological Products (China) Product
Table 103. Lanzhou Institute of Biological Products (China) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 104. Lanzhou Institute of Biological Products (China) Recent Development
Table 105. Mentor Corporation and Metabiologics (U.S.) Company Details
Table 106. Mentor Corporation and Metabiologics (U.S.) Business Overview
Table 107. Mentor Corporation and Metabiologics (U.S.) Product
Table 108. Mentor Corporation and Metabiologics (U.S.) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 109. Mentor Corporation and Metabiologics (U.S.) Recent Development
Table 110. Merz Pharma (Germany) Business Overview
Table 111. Merz Pharma (Germany) Product
Table 112. Merz Pharma (Germany) Company Details
Table 113. Merz Pharma (Germany) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 114. Merz Pharma (Germany) Recent Development
Table 115. Allergan (Irish) Company Details
Table 116. Allergan (Irish) Business Overview
Table 117. Allergan (Irish) Product
Table 118. Allergan (Irish) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 119. Allergan (Irish) Recent Development
Table 120. Galderma (Switzerland) Company Details
Table 121. Galderma (Switzerland) Business Overview
Table 122. Galderma (Switzerland) Product
Table 123. Galderma (Switzerland) Revenue in Botulism Treatment Business (2015-2020) (Million US$)
Table 124. Galderma (Switzerland) Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botulism Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antitoxin Features
Figure 3. Antibiotics Features
Figure 4. Others Features
Figure 5. Global Botulism Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals and Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Botulism Treatment Report Years Considered
Figure 9. Global Botulism Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Botulism Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Botulism Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Botulism Treatment Market Share by Players in 2019
Figure 14. Global Top Botulism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botulism Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Botulism Treatment Revenue in 2019
Figure 16. North America Botulism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Botulism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Botulism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Botulism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Botulism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Botulism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Botulism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
ジフテリア治療の世界市場（～2026年） Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing severe sore throat and fever leading to narrowing of the air passages and barking cough. Diphtheria may also affect the skin, eyes, or genitals and may cause myocarditis, bleeding and kidney problems. The …- 早期陣痛治療の世界市場（～2026年） Preterm labor is defined as regular contractions of the uterus resulting in changes in the cervix that start before 37 weeks of pregnancy. Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market. Market Analysis and Insights: Global …
- 交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
- 胃炎治療の世界市場（～2026年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …
- 鳥インフルエンザ治療の世界市場（～2026年） Bird flu is a viral infection caused by avian influenza A viruses in birds. The viruses that cause the disease in birds can mutate and spread to humans. Bird flu is named H or N depending on the protein found on the surface of the virus. Out of the three types of influenza viruses (A, B, and C), inf…